Publication:
舉重運動員補充HMB對骨質代謝之影響

Simple item page
dc.contributor.advisor洪暐
dc.contributor.advisorHung, Wei
dc.creator林家成
dc.creatorLin, Jia-cheng
dc.date2012
dc.date.accessioned2017-02-27T07:40:42Z
dc.date.accessioned2025-07-30T15:31:14Z
dc.date.available2017-02-27T07:40:42Z
dc.date.issued2017-02-27T07:40:42Z
dc.description學位類別：碩士
dc.description校院名稱：國立臺灣體育運動大學
dc.description系所名稱：運動健康科學系碩士班
dc.description學號：19806002
dc.description畢業學年度：100年
dc.description論文頁數：120頁
dc.description.abstract　　於長時間的訓練過程中，運動員經常藉由補充各式各樣的營養補充品以提升訓練效果，並修補恢復運動時所受到的各種傷害，進而防範可能發生的重大運動傷害，如疲勞性骨折等須長時間復原的傷害。β-羥基-β-甲基丁酸(beta-hydroxy-beta-methylbutyrate, HMB)目前已被廣泛用來提升肌力、增加骨骼肌含量與提升疲勞恢復等，近年來的研究則指出，HMB可能具有影響骨質代謝之作用，因此本研究欲探討舉重運動員在長期訓練中補充HMB後，對骨質代謝產生的影響；探討補充HMB後，對於血液中骨質代謝指標與單核前驅細胞內細胞蛋白的影響。自國立臺灣體育運動大學舉重代表隊招募16名健康的男性受試者，分為補充HMB組與補充安慰劑組。於為期一個月的訓練週期內，每天補充3 g HMB，並紀錄飲食狀況與填寫運動回顧問卷，訓練強度根據由教練所指示之訓練計畫，每週進行採血。分析血液中骨調控細胞激素OPG (osteoprotegerin)與sRANKL(soluble receptor activator of nuclear factor κB ligand)，骨骼代謝指標B-ALP(bone-specific alkaline phosphatase)、osteocalcin與beta-crosslaps，血液荷爾蒙PTH(parathyroid hormone)與cortisol，血液單核球中的細胞蛋白IκB-α (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha)與單核細胞膜上的receptor activator of nuclear factor κB (RANK)。結果顯示，骨合成指標B-ALP顯著且持續上升至訓練期結束，且於第三週組間達顯著差異；osteocalcin則兩組皆呈現明顯上升之趨勢，然組間並無明顯差異；骨分解指標beta-crosslaps，HMB組四週皆無明顯變化，placebo組則呈現持續上升之趨勢，並於後兩週達顯著；PTH兩組於後兩週皆明顯的上升，然組間並無顯著差異；cortisol於HMB組第一週達顯著上升後，隨後恢復至訓練前水平；sRANKL兩組呈現出不同的變化趨勢；OPG與訓練量呈現出相似的變化趨勢，RANK於placebo組第一週達顯著性的上升，隨後恢復至訓練前水平；IκB-α兩組自第一週起即顯著的下降，placebo組維持第一週水平至訓練結束，而HMB組則持續下降至訓練期結束，並於第四週兩組達顯著性差異。本研究主要發現，舉重選手於為期四週的訓練週期中，每日補充3克HMB，除了因訓練所提升骨質礦化作用外，還能額外提升造骨細胞的活性，提高骨質的合成作用；另一方面能有效減少，由運動刺激所造成的骨質分解作用。
dc.description.abstract　　Recently, beta-hydroxy-beta-methylbutyrate (HMB) is one of the dietary supplements promoted to enhance gains in strength and lean body mass associated with resistance training. Besides, some animal studies indicate that HMB may have the relationship with bone metabolic. Thus this research aims to discuss the effects of HMB supplement on bone biomarker in weightlifters during the training session. Sixteen healthy male weightlifters were recruited from university weightlifting team, and divided into two groups. During the training session, all subjects were asked to follow the training program previously designed by coach. They were took 3(g) HMB daily, and fasting blood sample was taken once a week. Bone cytokine OPG and RANKL, and bone specific biochemical markers including osteocalcin, beta-corsslaps, , bone-specific alkaline phosphatase (B-ALP), and hormones parathyroid hormone (PTH) and cortisol, and the expression of the osteoclastogenesis-related protein RANK and IκB-α levels were analyzed to evaluate the bone metabolic status. The results show that bone formation markers osteocalcin continuously increased, accompanied with increased bone resorption marker beta-corsslaps and reached a significant level in the last two weeks, and PTH had the similar tendency. In addition, IκB-α decreased siginificantly in the first week and maintained its level until the end of the training. However in group HMB, B-ALP was significantly higher in the third week and IκB-α significantly lower in the fourth week. Besides, sRANKL and beta-crosslaps appeared have a different tendency in the training session. This research found out that those weightlifters who took 3g HMB daily during the four-week training period could additionally increase the bone formation rate. In addition, it could effectively inhibit the bone resorption rate caused by training.
dc.description.tableofcontents目　次 第壹章　緒論………………………………………………………1 　第一節　研究背景………………………………………………1 　第二節　研究目的………………………………………………3 　第三節　研究假設………………………………………………3 第貳章　文獻探討…………………………………………………4 　第一節　骨質代謝機制…………………………………………4 　第二節　運動中骨質代謝的機制………………………………10 　第三節　關於HMB ………………………………………………16 　第四節　補充HMB對骨質的影響 ………………………………22 　第五節　HMB對造、破骨細胞生成的影響 ……………………24 　第六節　本章總結………………………………………………33 第參章　研究方法…………………………………………………35 　第一節　實驗樣本的來源及控制………………………………35 　第二節　實驗設計………………………………………………35 　第三節　實驗流程………………………………………………36 　第四節　血液樣本採集…………………………………………37 　第五節　血液分析與方法………………………………………37 　第六節　細胞蛋白分析…………………………………………42 　第七節　資料處理與統計分析…………………………………45 第肆章　結果………………………………………………………46 　第一節　受試者基本資料………………………………………46 　第二節　訓練量與肌肉損傷指標………………………………46 　第三節　單核細胞表面RANK與細胞內IκB-α生成結果………46 　第四節　骨質代謝指標之結果…………………………………47 　第五節　骨質代謝相關荷爾蒙之結果…………………………48 　第六節　骨調控蛋白之結果……………………………………48 第伍章　討論………………………………………………………49
dc.format.extent656772 bytes
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://ir.ntus.edu.tw/handle/987654321/71140
dc.languagezh-TW
dc.publisher運動健康科學系碩士班
dc.relation.isbasedonAbu, E. O., Horner, A., Kusec, V., Triffitt, J. T., & Compston, J. E. (1997). The localization of androgen receptors in human bone. The Journal of Clinical Endocrinology and Metabolism, 82(10), 3493-3497. Adami, S., Zivelonghi, A., Braga, V., Fracassi, E., Gatti, D., Rossini, M., et al. (2010). Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. Bone, 46(1), 244-247. Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000). A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature, 404(6774), 193-197. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., et al. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390(6656), 175-179. Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., et al. (1999). Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. The Journal of Experimental Medicine, 190(12), 1741-1754. Ashizawa, N., Ouchi, G., Fujimura, R., Yoshida, Y., Tokuyama, K., & Suzuki, M. (1998). Effects of a single bout of resistance exercise on calcium and bone metabolism in untrained young males. Calcified Tissue International, 62(2), 104-108. Atherton, P. J., Babraj, J., Smith, K., Singh, J., Rennie, M. J., & Wackerhage, H. (2005). Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. Federation of American Societies for Experimental Biology, 19(7), 786-788. Atkins, G. J., Kostakis, P., Vincent, C., Farrugia, A. N., Houchins, J. P., Findlay, D. M., et al. (2006). RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Journal of Bone and Mineral Research, 21(9), 1339-1349. Bai, X. C., Lu, D., Liu, A. L., Zhang, Z. M., Li, X. M., Zou, Z. P., et al. (2005). Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. The Journal of Biological Chemistry, 280(17), 17497-17506. Baksh, D., Song, L., & Tuan, R. S. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine, 8(3), 301-316. Barry, D. W., & Kohrt, W. M. (2007). Acute effects of 2 hours of moderate-intensity cycling on serum parathyroid hormone and calcium. Calcified Tissue International, 80(6), 359-365. Bastiaanse, E. M., Hold, K. M., & Van der Laarse, A. (1997). The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovascular Research, 33(2), 272-283. Bieñko, M., Radzki, R. P., Kapica, M., Puzio, I., Filip, R., & Paw£owska, M. (2006). Influence of beta-hydroxy-beta-methylbutyrate (HMB) on the structural strength of bones. Medycyna Weterynaryjna, 62(8), 963-965. Black, D., Duncan, A., & Robins, S. P. (1988). Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Analytical Biochemistry, 169(1), 197-203. Bourrin, S., Palle, S., Pupier, R., Vico, L., & Alexandre, C. (1995). Effect of physical training on bone adaptation in three zones of the rat tibia. Journal of Bone and Mineral Research, 10(11), 1745-1752. Boyce, B. F., Yamashita, T., Yao, Z., Zhang, Q., Li, F., & Xing, L. (2005). Roles for NF-kappaB and c-Fos in osteoclasts. Journal of Bone and Mineral Metabolism, 23(Suppl), 11-15. Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423(6937), 337-342. Breier, B. H. (1999). Regulation of protein and energy metabolism by the somatotropic axis. Domestic Animal Endocrinology, 17(2-3), 209-218. Casez, J. P., Fischer, S., Stussi, E., Stalder, H., Gerber, A., Delmas, P. D., et al. (1995). Bone mass at lumbar spine and tibia in young males--impact of physical fitness, exercise, and anthropometric parameters: a prospective study in a cohort of military recruits. Bone, 17(3), 211-219. Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., et al. (2003). Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia, 17(7), 1263-1293. Chen, L. F., & Greene, W. C. (2004). Shaping the nuclear action of NF-kappaB. Nature Reviews Molecular Cell Biology, 5(5), 392-401. Cheng W, P. B., & N, A. (1997). Beta-hydroxy-beta-methylbutyrate increases fatty acid oxidation by muscle cells. Federation of American Societies for Experimental Biology, 11, A381. Coelho, C. W., & Carvalho, T. (2001). Effects of HMB supplementation on LDL-cholesterol, strength and body composition of patients with hypercholesterolemia. Medicine and Science in Sports and Exercise, 33(5), S340. Creighton, D. L., Morgan, A. L., Boardley, D., & Brolinson, P. G. (2001). Weight-bearing exercise and markers of bone turnover in female athletes. Journal of Applied Physiology, 90(2), 565-570. Crespo, R., Revilla, M., Villa, L. F., Usabiaga, J., Leibar, X., & Rico, H. (1999). Transient dissociation of bone metabolism induced by high performance exercise: a study in elite marathon runners. Calcified Tissue International, 64(4), 287-290. Crespo, R., Stover, S. M., Taylor, K. T., Chin, R. P., & Shivaprasad, H. L. (2000). Morphometric and mechanical properties of femora in young adult male turkeys with and without femoral fractures. Poultry Science, 79(4), 602-608. Delaisse, J. M., Andersen, T. L., Engsig, M. T., Henriksen, K., Troen, T., & Blavier, L. (2003). Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microscopy Research and Technique, 61(6), 504-513. Eley, H. L., Russell, S. T., Baxter, J. H., Mukerji, P., & Tisdale, M. J. (2007). Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. American Journal of Physiology, 293(4), E923-931. Eriksen, E. F., Charles, P., Melsen, F., Mosekilde, L., Risteli, L., & Risteli, J. (1993). Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. Journal of Bone and Mineral Research, 8(2), 127-132. Frost, H. M. (1988). Vital biomechanics: proposed general concepts for skeletal adaptations to mechanical usage. Calcified Tissue International, 42(3), 145-156. Fujimura, R., Ashizawa, N., Watanabe, M., Mukai, N., Amagai, H., Fukubayashi, T., et al. (1997). Effect of resistance exercise training on bone formation and resorption in young male subjects assessed by biomarkers of bone metabolism. Journal of Bone and Mineral Research, 12(4), 656-662. Gallagher, P. M., Carrithers, J. A., Godard, M. P., Schulze, K. E., & Trappe, S. W. (2000). Beta-hydroxy-beta-methylbutyrate ingestion, Part I: effects on strength and fat free mass. Medicine and Science in Sports and Exercise, 32(12), 2109-2115. Garcia-Lopez, D., Cuevas, M. J., Almar, M., Lima, E., De Paz, J. A., & Gonzalez-Gallego, J. (2007). Effects of eccentric exercise on NF-kappaB activation in blood mononuclear cells. Medicine and Science in Sports and Exercise, 39(4), 653-664. Garnero, P., & Delmas, P. D. (1993). Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. The Journal of Clinical Endocrinology and Metabolism, 77(4), 1046-1053. Gordeladze, J. O., Drevon, C. A., Syversen, U., & Reseland, J. E. (2002). Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. Journal of Cellular Biochemistry, 85(4), 825-836. Ha, H., Kwak, H. B., Lee, S. W., Jin, H. M., Kim, H. M., Kim, H. H., et al. (2004). Reactive oxygen species mediate RANK signaling in osteoclasts. Experimental Cell Research, 301(2), 119-127. Hamdy, R. C., Anderson, J. S., Whalen, K. E., & Harvill, L. M. (1994). Regional differences in bone density of young men involved in different exercises. Medicine and Science in Sports and Exercise, 26(7), 884-888. Harada, S., & Rodan, G. A. (2003). Control of osteoblast function and regulation of bone mass. Nature, 423(6937), 349-355. Ho, R. C., Hirshman, M. F., Li, Y., Cai, D., Farmer, J. R., Aschenbach, W. G., et al. (2005). Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. American Physiological SocietyAmerican Journal of Physiology, 289(4), C794-801. Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., et al. (1999). Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology, 140(10), 4382-4389. Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000). The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Mineral Research, 15(1), 2-12. Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999). Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology, 140(9), 4367-4370. Holecek, M., Muthny, T., Kovarik, M., & Sispera, L. (2009). Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food and Chemical Toxicology, 47(1), 255-259. Hollander, J., Fiebig, R., Gore, M., Ookawara, T., Ohno, H., & Ji, L. L. (2001). Superoxide dismutase gene expression is activated by a single bout of exercise in rat skeletal muscle. Pflugers Archiv-European Journal of Physiology, 442(3), 426-434. Ji, L. L., Gomez-Cabrera, M. C., Steinhafel, N., & Vina, J. (2004). Acute exercise activates nuclear factor (NF)-kappaB signaling pathway in rat skeletal muscle. Federation of American Societies for Experimental Biology, 18(13), 1499-1506. Jimenez-Jimenez, R., Cuevas, M. J., Almar, M., Lima, E., Garcia-Lopez, D., De Paz, J. A., et al. (2008). Eccentric training impairs NF-kappaB activation and over-expression of inflammation-related genes induced by acute eccentric exercise in the elderly. Mechanisms of Ageing and Development, 129(6), 313-321. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., et al. (2004). Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nature Medicine, 10(6), 617-624. Jowko, E., Ostaszewski, P., Jank, M., Sacharuk, J., Zieniewicz, A., Wilczak, J., et al. (2001). Creatine and beta-hydroxy-beta-methylbutyrate (HMB) additively increase lean body mass and muscle strength during a weight-training program. Nutrition, 17(7-8), 558-566. Kamata, H., Manabe, T., Oka, S., Kamata, K., & Hirata, H. (2002). Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. Federation of European Biochemical Societies, 519(1-3), 231-237. Kanbur, N. Ö., Derman, O., & Kınık, E. (2005). The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents. Journal of Bone and Mineral Metabolism, 23(1), 76-83. Karin, M., Yamamoto, Y., & Wang, Q. M. (2004). The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews Drug Discovery, 3(1), 17-26. Karlsson, K. M., Karlsson, C., Ahlborg, H. G., Valdimarsson, O., & Ljunghall, S. (2003). The duration of exercise as a regulator of bone turnover. Calcified Tissue International, 73(4), 350-355. Karlsson, M. K., Vergnaud, P., Delmas, P. D., & Obrant, K. J. (1995). Indicators of bone formation in weight lifters. Calcified Tissue International, 56(3), 177-180. Katharina, K.-S., Markus, T., Gottfried, H. S., Katerina, S., Antonia, L. M., Stephan, G., et al. (2009). A 246-km continuous running race causes significant changes in bone metabolism. Bone, 45(6), 1079-1083. Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008). Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocrine Reviews, 29(2), 155-192. Kim, C. H., You, L., Yellowley, C. E., & Jacobs, C. R. (2006). Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. Bone, 39(5), 1043-1047. Kim, S. Y., Jun, T. W., Lee, Y. S., Na, H. K., Surh, Y. J., & Song, W. (2009). Effects of exercise on cyclooxygenase-2 expression and nuclear factor-kappaB DNA binding in human peripheral blood mononuclear cells. Annals of the New York Academy of Sciences, 1171, 464-471. Knitter, A. E., Panton, L., Rathmacher, J. A., Petersen, A., & Sharp, R. (2000). Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. Journal of Applied Physiology, 89(4), 1340-1344. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., et al. (2005). NFAT and Osterix cooperatively regulate bone formation. Nature Medicine, 11(8), 880-885. Koh, J. M., Lee, Y. S., Kim, Y. S., Kim, D. J., Kim, H. H., Park, J. Y., et al. (2006). Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. Journal of Bone and Mineral Research, 21(7), 1003-1011. Kornasio, R., Riederer, I., Butler-Browne, G., Mouly, V., Uni, Z., & Halevy, O. (2009). Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochimica et Biophysica Acta, 1793(5), 755-763. Kramer, H. F., & Goodyear, L. J. (2007). Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. Journal of Applied Physiology, 103(1), 388-395. Kreider, R. B., Ferreira, M., Greenwood, M., Wilson, M., Grindstaff, P., Plisk, S., et al. (2000). Exercise nutrition effects of calcium beta-HMB supplementation during training on markers of catabolism, body composition, strength and sprint performance. Journal of Exercise Physiology, 3(4), 48-59. Kreider, R. B., Ferreira, M., Wilson, M., & Almada, A. L. (1999). Effects of calcium beta-hydroxy-beta-methylbutyrate (HMB) supplementation during resistance-training on markers of catabolism, body composition and strength. International Journal of Sports Medicine, 20(8), 503-509. Kukita, T., Wada, N., Kukita, A., Kakimoto, T., Sandra, F., Toh, K., et al. (2004). RANKL-induced DC-STAMP is essential for osteoclastogenesis. The Journal of Experimental Medicine, 200(7), 941. Lacey, D., Timms, E., Tan, H., Kelley, M., Dunstan, C., Burgess, T., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93(2), 165-176. Langberg, H., Skovgaard, D., Asp, S., & Kjaer, M. (2000). Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcified Tissue International, 67(1), 41-44. Lanyon, L. E. (1992). Control of bone architecture by functional load bearing. Journal of Bone and Mineral Research, 7 (Suppl 2), S369-375. Lee, N. K., Choi, Y. G., Baik, J. Y., Han, S. Y., Jeong, D. W., Bae, Y. S., et al. (2005). A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood, 106(3), 852-859. Leeuwenburgh, C., & Heinecke, J. W. (2001). Oxidative stress and antioxidants in exercise. Current Medicinal Chemistry, 8(7), 829-838. Li, J., Sarosi, I., Yan, X. Q., Morony, S., Capparelli, C., Tan, H. L., et al. (2000). RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1566-1571. Lima, F., De Falco, V., Baima, J., Carazzato, J. G., & Pereira, R. M. (2001). Effect of impact load and active load on bone metabolism and body composition of adolescent athletes. Medicine and Science in Sports and Exercise, 33(8), 1318-1323. Lorenzo, J. A., Sousa, S. L., Fonseca, J. M., Hock, J. M., & Medlock, E. S. (1987). Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. The Journal of Clinical Investigation, 80(1), 160-164. Maimoun, L., Manetta, J., Couret, I., Dupuy, A. M., Mariano-Goulart, D., Micallef, J. P., et al. (2006). The intensity level of physical exercise and the bone metabolism response. International Journal of Sports Medicine, 27(2), 105-111. Maimoun, L., Simar, D., Caillaud, C., Coste, O., Barbotte, E., Peruchon, E., et al. (2009). Response of calciotropic hormones and bone turnover to brisk walking according to age and fitness level. Journal of Sports Science and Medicine, 12(4), 463-467. Malm, H. T., Ronni-Sivula, H. M., Viinikka, L. U., & Ylikorkala, O. R. (1993). Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcified Tissue International, 52(3), 209-211. Margonis, K., Fatouros, I. G., Jamurtas, A. Z., Nikolaidis, M. G., Douroudos, I., Chatzinikolaou, A., et al. (2007). Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis. Free Radical Biology and Medicine, 43(6), 901-910. Matsubara, T., Kida, K., Yamaguchi, A., Hata, K., Ichida, F., Meguro, H., et al. (2008). BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. The Journal of Biological Chemistry, 283(43), 29119-29125. Memmott, R. M., & Dennis, P. A. (2009). Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cell Signal, 21(5), 656-664. Miyazaki, H., Oh-ishi, S., Ookawara, T., Kizaki, T., Toshinai, K., Ha, S., et al. (2001). Strenuous endurance training in humans reduces oxidative stress following exhausting exercise. European Journal of Applied Physiology, 84(1-2), 1-6. Morel, J., Combe, B., Francisco, J., & Bernard, J. (2001). Bone mineral density of 704 amateur sportsmen involved in different physical activities. Osteoporosis International 12(2), 152-157. Mouzopoulos, G., Stamatakos, M., Tzurbakis, M., Tsembeli, A., Manti, C., Safioleas, M., et al. (2007). Changes of bone turnover markers after marathon running over 245 km. International Journal of Sports Medicine, 28(7), 576-579. Muller, J. M., Rupec, R. A., & Baeuerle, P. A. (1997). Study of gene regulation by NF-kappaB and AP-1 in response to reactive oxygen intermediates. Methods, 11(3), 301-312. Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., et al. (1998). RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochemical and Biophysical Research Communications, 253(2), 395-400. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., et al. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108(1), 17-29. Nicholson, G. C., Malakellis, M., Collier, F. M., Cameron, P. U., Holloway, W. R., Gough, T. J., et al. (2000). Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clinical Science, 99(2), 133-140. Nishiyama, S., Tomoeda, S., Ohta, T., Higuchi, A., & Matsuda, I. (1988). Differences in basal and postexercise osteocalcin levels in athletic and nonathletic humans. Calcified Tissue International, 43(3), 150-154. Nissen, S. L., & Abumrad, N. N. (1997). Nutritional role of the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB). The Journal of Nutritional Biochemistry, 8(6), 300-311. Nissen, S. L., Sharp, R., Ray, M., Rathmacher, J. A., Rice, D., Fuller, J. C., Jr., et al. (1996). Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. Journal of Applied Physiology, 81(5), 2095-2104. Nissen, S. L., & Sharp, R. L. (2003). Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. Journal of Applied Physiology, 94(2), 651-659. Noble, B. (2003). Bone microdamage and cell apoptosis. eCells and Materials Journal, 6, 46-55; discusssion 55. Nowak, A., Stemplewski, R., Szeklicki, R., Karolkiewicz, J., Pilaczynska-Szczesniak, L., & Osinski, W. (2005). Biochemical markers of bone metabolism in healthy elderly men. The relationship to physical activity. Aging Male, 8(2), 75-80. Nunes, E. A., Kuczera, D., Brito, G. A., Bonatto, S. J., Yamazaki, R. K., Tanhoffer, R. A., et al. (2008). Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nutrition Research, 28(7), 487-493. O'Connor, D. M., & Crowe, M. J. (2003). Effects of beta-hydroxy-beta-methylbutyrate and creatine monohydrate supplementation on the aerobic and anaerobic capacity of highly trained athletes. The Journal of Sports Medicine and Physical Fitness, 43(1), 64-68. O'Connor, D. M., & Crowe, M. J. (2007). Effects of six weeks of beta-hydroxy-beta-methylbutyrate (HMB) and HMB/creatine supplementation on strength, power, and anthropometry of highly trained athletes. The Journal of Strength and Conditioning Research, 21(2), 419-423. Ortenblad, N., Madsen, K., & Djurhuus, M. S. (1997). Antioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans. American Journal of Physiology, 272(4 Pt 2), R1258-1263. Pahl, H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18(49), 6853-6866. Panton, L. B., Rathmacher, J. A., Baier, S., & Nissen, S. (2000). Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training. Nutrition, 16(9), 734-739. Pavlin, D., & Gluhak-Heinrich, J. (2001). Effect of mechanical loading on periodontal cells. Critical Reviews in Oral Biology and Medicine, 12(5), 414-424. Pierno, S., De Luca, A., Tricarico, D., Roselli, A., Natuzzi, F., Ferrannini, E., et al. (1995). Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. Journal of Pharmacology and Experimental Therapeutics, 275(3), 1490-1496. Pitkänen, H. T., Oja, S. S., Rusko, H., Nummela, A., Komi, P. V., Saransaari, P., et al. (2003). Leucine supplementation does not enhance acute strength or running performance but affects serum amino acid concentration. Amino Acids, 25(1), 85-94. Portal, S., Eliakim, A., Nemet, D., Halevy, O., & Zadik, Z. (2010). Effect of HMB supplementation on body composition, fitness, hormonal profile and muscle damage indices. Journal of Pediatric Endocrinology and Metabolism, 23(7), 641-650. Portal, S., Zadik, Z., Rabinowitz, J., Pilz-Burstein, R., Adler-Portal, D., Meckel, Y., et al. (2011). The effect of HMB supplementation on body composition, fitness, hormonal and inflammatory mediators in elite adolescent volleyball players: a prospective randomized, double-blind, placebo-controlled study. European Journal of Applied Physiology, 111(9), 2261-2269. Powers, S. K., Ji, L. L., & Leeuwenburgh, C. (1999). Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Medicine and Science in Sports and Exercise, 31(7), 987-997. Powers, S. K., & Lennon, S. L. (1999). Analysis of cellular responses to free radicals: focus on exercise and skeletal muscle. Proceedings of the Nutrition Society, 58(4), 1025-1033. Price, P. A., Williamson, M. K., & Lothringer, J. W. (1981). Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. The Journal of Biological Chemistry, 256(24), 12760-12766. Pruitt, L. A., Jackson, R. D., Bartels, R. L., & Lehnhard, H. J. (1992). Weight-training effects on bone mineral density in early postmenopausal women. Journal of Bone and Mineral Research, 7(2), 179-185. Pryor, W. A. (1991). The antioxidant nutrients and disease prevention--what do we know and what do we need to find out? The American Journal of Clinical Nutrition, 53(1 Suppl), 391S-393S. Radak, Z., Chung, H. Y., Koltai, E., Taylor, A. W., & Goto, S. (2008). Exercise, oxidative stress and hormesis. Ageing Research Reviews, 7(1), 34-42. Radomisli, T. E., Moore, D. C., Barrach, H. J., Keeping, H. S., & Ehrlich, M. G. (2001). Weight-bearing alters the expression of collagen types I and II, BMP 2/4 and osteocalcin in the early stages of distraction osteogenesis. Journal of Orthopaedic Research 19(6), 1049-1056. Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003). Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. The Journal of Clinical Investigation, 111(6), 821-831. Rizzoli, R., Bonjour, J. P., & Ferrari, S. L. (2001). Osteoporosis, genetics and hormones. Journal of Molecular Endocrinology 26(2), 79-94. Rong, H., Berg, U., Torring, O., Sundberg, C. J., Granberg, B., & Bucht, E. (1997). Effect of acute endurance and strength exercise on circulating calcium-regulating hormones and bone markers in young healthy males. Scandinavian Journal of Medicine and Science in Sports, 7(3), 152-159. Roodman, G. D. (2006). Regulation of osteoclast differentiation. Annals of the New York Academy of Sciences, 1068(1), 100-109. Rowlands, D. S., & Thomson, J. S. (2009). Effects of beta-hydroxy-beta-methylbutyrate supplementation during resistance training on strength, body composition, and muscle damage in trained and untrained young men: a meta-analysis. The Journal of Strength and Conditioning Research, 23(3), 836-846. Rubin, J., Ackert-Bicknell, C. L., Zhu, L., Fan, X., Murphy, T. C., Nanes, M. S., et al. (2002). IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. The Journal of Clinical Endocrinology and Metabolism, 87(9), 4273-4279. Rubin, J., Fan, X., Biskobing, D. M., Taylor, W. R., & Rubin, C. T. (1999). Osteoclastogenesis is repressed by mechanical strain in an in vitro model. Journal of Orthopaedic Research 17(5), 639-645. Rubin, J., Murphy, T., Nanes, M. S., & Fan, X. (2000). Mechanical strain inhibits expression of osteoclast differentiation factor by murine stromal cells. American Physiological SocietyAmerican Journal of Physiology, 278(6), C1126-1132. Ruimerman, R., Hilbers, P., van Rietbergen, B., & Huiskes, R. (2005). A theoretical framework for strain-related trabecular bone maintenance and adaptation. Journal of Biomechanics, 38(4), 931-941. Russell, S. T., & Tisdale, M. J. (2009). Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide. Molecular and Cellular Biochemistry, 330(1-2), 171-179. Ryan, A. S., Treuth, M. S., Rubin, M. A., Miller, J. P., Nicklas, B. J., Landis, D. M., et al. (1994). Effects of strength training on bone mineral density: hormonal and bone turnover relationships. Journal of Applied Physiology, 77(4), 1678-1684. Sabourin, P. J., & Bieber, L. L. (1983). Formation of beta-hydroxyisovalerate by an alpha-ketoisocaproate oxygenase in human liver. Metabolism, 32(2), 160-164. Sadideen, H., & Swaminathan, R. (2004). Effect of acute oral calcium load on serum PTH and bone resorption in young healthy subjects: an overnight study. European Journal of Clinical Nutrition, 58(12), 1661-1665. Saunders, M. M., Taylor, A. F., Du, C., Zhou, Z., Pellegrini, V. D., Jr., & Donahue, H. J. (2006). Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. Journal of Biomechanics, 39(8), 1419-1427. Schett, G., Kiechl, S., Redlich, K., Oberhollenzer, F., Weger, S., Egger, G., et al. (2004). Soluble RANKL and risk of nontraumatic fracture. The Journal of the American Medical Association, 291(9), 1108-1113. Schoppet, M., Preissner, K. T., & Hofbauer, L. C. (2002). RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arteriosclerosis, Thrombosis, and Vascular Biology, 22(4), 549-553. Seibel, M. J. (2005). Biochemical markers of bone turnover: part I: biochemistry and variability. The Clinical Biochemist Reviews, 26(4), 97-122. Shackelford, L. C., LeBlanc, A. D., Driscoll, T. B., Evans, H. J., Rianon, N. J., Smith, S. M., et al. (2004). Resistance exercise as a countermeasure to disuse-induced bone loss. Journal of Applied Physiology, 97(1), 119-129. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., et al. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89(2), 309-319. Singh, H., Sen, R., Baltimore, D., & Sharp, P. A. (1986). A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature, 319(6049), 154-158. Smith, H. J., Mukerji, P., & Tisdale, M. J. (2005). Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss. Cancer Research, 65(1), 277-283. Smith, H. J., Wyke, S. M., & Tisdale, M. J. (2004). Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Research, 64(23), 8731-8735. Soysa, N. S., & Alles, N. (2009). NF-kappaB functions in osteoclasts. Biochemical and Biophysical Research Communications, 378(1), 1-5. Spangenburg, E. E., Brown, D. A., Johnson, M. S., & Moore, R. L. (2006). Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. The Journal of Physiology, 572(Pt 3), 839-848. Stein, G. S., Lian, J. B., Stein, J. L., Van Wijnen, A. J., & Montecino, M. (1996). Transcriptional control of osteoblast growth and differentiation. Physiological Reviews, 76(2), 593-629. Stewart, A. D., & Hannan, J. (2000). Total and regional bone density in male runners, cyclists, and controls. Medicine and Science in Sports and Exercise, 32(8), 1373-1377. Suominen, H. (1993). Bone mineral density and long term exercise. An overview of cross-sectional athlete studies. Sports Medicine, 16(5), 316-330. Tak, P. P., & Firestein, G. S. (2001). NF-kappaB: a key role in inflammatory diseases. The Journal of Clinical Investigation, 107(1), 7-11. Takada, I., Kouzmenko, A. P., & Kato, S. (2009). Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nature Reviews Rheumatology, 5(8), 442-447. Tang, L., Lin, Z., & Li, Y. M. (2006). Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. Biochemical and Biophysical Research Communications, 344(1), 122-128. Tatara, M. R. (2008b). Neonatal programming of skeletal development in sheep is mediated by somatotrophic axis function. Experimental Physiology, 93(6), 763-772. Tatara, M. R. (2009). Effect of beta-hydroxy beta-methylbutyrate (HMB) administration on volumetric bone mineral density, and morphometric and mechanical properties of tibia in male turkeys. Journal of Animal Physiology and Animal Nutrition, 93(6), 669-677. Tatara, M. R., Sliwa, E., & Krupski, W. (2007). Prenatal programming of skeletal development in the offspring: effects of maternal treatment with beta-hydroxy-beta-methylbutyrate (HMB) on femur properties in pigs at slaughter age. Bone, 40(6), 1615-1622. Tatara, M. R., Sliwa, E., Krupski, W., & Worzakowska, M. (2008a). 3-Hydroxy-3-methylbutyrate administration diminishes fundectomy-induced osteopenia of the lumbar spine in pigs. Nutrition, 24(7-8), 753-760. Teitelbaum, S. L. (2000). Bone resorption by osteoclasts. Science, 289(5484), 1504-1508. Theill, L. E., Boyle, W. J., & Penninger, J. M. (2002). RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annual Review of Immunology, 20, 795-823. Thomson, J. S., Watson, P. E., & Rowlands, D. S. (2009). Effects of nine weeks of beta-hydroxy-beta- methylbutyrate supplementation on strength and body composition in resistance trained men. The Journal of Strength and Conditioning Research, 23(3), 827-835. Tisdale, M. J. (2005). The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. The Journal of Supportive Oncology 3(3), 209-217. Vaira, S., Alhawagri, M., Anwisye, I., Kitaura, H., Faccio, R., & Novack, D. V. (2008). RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. The Journal of Clinical Investigation, 118(6), 2088-2097. van Koevering, M., & Nissen, S. (1992). Oxidation of leucine and alpha-ketoisocaproate to beta-hydroxy-beta-methylbutyrate in vivo. American Journal of Physiology, 262, E27-31. van Someren, K. A., Edwards, A. J., & Howatson, G. (2005). Supplementation with beta-hydroxy-beta-methylbutyrate (HMB) and alpha-ketoisocaproic acid (KIC) reduces signs and symptoms of exercise-induced muscle damage in man. International Journal of Sport Nutrition and Exercise Metabolism, 15(4), 413-424. Vider, J., Laaksonen, D. E., Kilk, A., Atalay, M., Lehtmaa, J., Zilmer, M., et al. (2001). Physical exercise induces activation of NF-kappaB in human peripheral blood lymphocytes. Antioxid Redox Signal, 3(6), 1131-1137. Virtanen, P., Viitasalo, J. T., Vuori, J., Vaananen, K., & Takala, T. E. (1993). Effect of concentric exercise on serum muscle and collagen markers. Journal of Applied Physiology, 75(3), 1272-1277. Vukovich, M. D., Stubbs, N. B., & Bohlken, R. M. (2001). Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults. Journal of Nutrition, 131(7), 2049-2052. Wagner, E. F., & Karsenty, G. (2001). Genetic control of skeletal development. Current Opinion in Genetics and Development, 11(5), 527-532. West, S. L., Scheid, J. L., & De Souza, M. J. (2009). The effect of exercise and estrogen on osteoprotegerin in premenopausal women. Bone, 44(1), 137-144. Wilson, G. J., Wilson, J. M., & Manninen, A. H. (2008). Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A review. Nutrition and Metabolism, 5, 1. Woitge, H. W., Friedmann, B., Suttner, S., Farahmand, I., Muller, M., Schmidt-Gayk, H., et al. (1998). Changes in bone turnover induced by aerobic and anaerobic exercise in young males. Journal of Bone and Mineral Research, 13(12), 1797-1804. Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., et al. (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. The Journal of Biological Chemistry, 272(40), 25190-25194. Xing, L., & Boyce, B. F. (2005). Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochemical and Biophysical Research Communications, 328(3), 709-720. Xing, L., Bushnell, T., Carlson, L., Tai, Z., Tondravi, M., Siebenlist, U., et al. (2002). NF-kappaB p50 and p52 expression is not required for RANK expressing osteoclast progenitor formation but is essential for RANK and cytokine mediated osteoclastogenesis. Journal of Bone and Mineral Research, 17(7), 1200-1210. Xing, L., & Schwarz, E. (2005). Circulating osteoclast precursors: a mechanism and a marker of erosive arthritis. Current Rheumatology Reviews, 1(1), 21-28. Xu, J., Wu, H. F., Ang, E. S., Yip, K., Woloszyn, M., Zheng, M. H., et al. (2009). NF-kappaB modulators in osteolytic bone diseases. Cytokine and Growth Factor Reviews, 20(1), 7-17. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., et al. (2005). DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. The Journal of Experimental Medicine, 202(3), 345-351. Yip, K., Zheng, M., Feng, H., Steer, J., Joyce, D., & Xu, J. (2004). Sesquiterpene lactone parthenolide blocks lipopolysaccharide induced osteolysis through the suppression of NF-kappaB activity. Journal of Bone and Mineral Research, 19(11), 1905-1916. Zaidi, M. (2007). Skeletal remodeling in health and disease. Nature Medicine, 13(7), 791-801. Zavrski, I., Krebbel, H., Wildemann, B., Heider, U., Kaiser, M., Possinger, K., et al. (2005). Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function. Biochemical and Biophysical Research Communications, 333(1), 200-205. Zhao, G., Monier-Faugere, M. C., Langub, M. C., Geng, Z., Nakayama, T., Pike, J. W., et al. (2000). Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology, 141(7), 2674-2682. Ziegler, S., Niessner, A., Richter, B., Wirth, S., Billensteiner, E., Woloszczuk, W., et al. (2005). Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. Metabolism, 54(7), 935-938.
dc.subjectβ-羥基-β-甲基丁酸;骨質代謝;負重性運動
dc.subjectbeta-hydroxy-beta-methylbutyrate;bone metabolic;weight-bearing exercise
dc.title舉重運動員補充HMB對骨質代謝之影響
dc.titleEFFECTS OF BETA-HYDROXY-BETA-METHYLBUTYRATE SUPPLEMENT ON BONE METABOLISM IN WEIGHTLIFTERS
dc.typethesis
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
0013001.pdf
Size:
641.38 KB
Format:
Adobe Portable Document Format
Download

Collections

學位論文(103學年度之前)